Terreno Realty Corp
TRNO NYSE Real Estate Financials FY2016βFY2025
What Terreno Realty Corp does
No business description yet.
- Legal name
- Terreno Realty Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 4, 2026
- Accession Β· CIK
- 0001476150-26-000011
0001476150
Revenue and margins
Terreno Realty Corp had $476M of revenue in fiscal 2025, up 24.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 35.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Terreno Realty Corp returned $207M to shareholders in fiscal 2025. The diluted share count rose 7.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Terreno Realty Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $204M | $26.4M | $165M | $18.1M | $25.0M |
| Debt incl. finance leases | $721M | $771M | $772M | $823M | $943M |
| Debt / equity | 0.4x | 0.3x | 0.3x | 0.2x | 0.2x |
| Total assets | $2.9B | $3.2B | $3.9B | $4.8B | $5.4B |
| Total liabilities | $866M | $935M | $990M | $1.1B | $1.2B |
| Shareholders' equity | $2.1B | $2.2B | $2.9B | $3.7B | $4.1B |
| Net debt (β = net cash) | $516M | $744M | $606M | $805M | $918M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 7 | 5 / 7 | 4 / 7 | 6 / 7 | 3 / 7 | 5 / 7 | 4 / 7 | 4 / 7 | 4 / 7 |
| Accruals ratio | β2.7% | β1.2% | β0.9% | β2.0% | β1.0% | β1.8% | 1.8% | β0.8% | β1.1% | 2.6% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $108M | $132M | $152M | $171M | $187M | $222M | $276M | $324M | $383M | $476M |
| Interest expense | $13.1M | $16.8M | $18.2M | $16.3M | $16.0M | $18.1M | $23.9M | $24.8M | $20.9M | $32.9M |
| Net income | $15.1M | $53.1M | $63.3M | $55.5M | $79.8M | $87.3M | $198M | $151M | $184M | $403M |
| Net income to common | $11.5M | $49.0M | $62.9M | $55.2M | $79.4M | $86.9M | $197M | $151M | $184M | $401M |
| Diluted EPS | $0.26 | $0.95 | $1.09 | $0.85 | $1.16 | $1.23 | $2.61 | $1.81 | $1.92 | $3.91 |
| Diluted shares | 0.04B | 0.05B | 0.06B | 0.06B | 0.07B | 0.07B | 0.08B | 0.08B | 0.10B | 0.10B |
| Cash flow | ||||||||||
| Cash from operations | $49.2M | $69.5M | $77.6M | $94.7M | $101M | $132M | $143M | $180M | $233M | $272M |
| Depreciation and amortization | $34.4M | $37.9M | $40.8M | $44.0M | $45.9M | $50.7M | $65.8M | $73.2M | $93.9M | $122M |
| Stock-based compensation | $9.4M | $8.7M | $9.3M | $10.6M | $9.8M | $9.6M | $10.2M | $13.5M | $14.9M | $17.7M |
| Share buybacks | $1.6M | $3.4M | $3.9M | $4.0M | $9.8M | $0.6M | $1.0M | $1.5M | $3.3M | $3.3M |
| Dividends paid | $33.2M | $41.9M | $51.4M | $63.6M | $74.8M | $84.6M | $107M | $136M | $175M | $204M |
| Dividends and buybacks | $34.7M | $45.3M | $55.3M | $67.5M | $84.6M | $85.2M | $108M | $137M | $178M | $207M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $14.2M | $35.7M | $31.0M | $110M | $107M | $204M | $26.4M | $165M | $18.1M | $25.0M |
| Total debt | $415M | $462M | $462M | $492M | $459M | $721M | $771M | $772M | $823M | $943M |
| Loans, net | β | $0.0M | $54.5M | $15.9M | β | β | β | β | β | β |
| Intangible assets | $18.1M | $4.1M | β | β | β | β | β | β | β | β |
| Total assets | $1.3B | $1.6B | $1.8B | $2.1B | $2.1B | $2.9B | $3.2B | $3.9B | $4.8B | $5.4B |
| Total liabilities | $467M | $540M | $549M | $591M | $552M | $866M | $935M | $990M | $1.1B | $1.2B |
| Preferred stock | $46.0M | β | β | β | β | β | β | β | β | β |
| Shareholders' equity | $812M | $1.0B | $1.2B | $1.5B | $1.6B | $2.1B | $2.2B | $2.9B | $3.7B | $4.1B |
| Margins | ||||||||||
| Net margin | 13.9% | 40.1% | 41.7% | 32.5% | 42.7% | 39.3% | 71.7% | 46.8% | 48.2% | 84.6% |
| Returns | ||||||||||
| Return on equity | 1.9% | 5.8% | 5.6% | 4.0% | 5.1% | 4.8% | 9.2% | 5.9% | 5.6% | 10.3% |
| Return on assets | 1.2% | 3.7% | 3.8% | 2.8% | 3.8% | 3.4% | 6.5% | 4.3% | 4.3% | 7.9% |
| Return on tangible equity | 1.4% | 4.8% | 5.0% | 3.6% | 5.0% | 4.2% | 8.8% | 5.2% | 5.0% | 9.7% |
| Growth | ||||||||||
| Revenue growth | β | 22.2% | 14.5% | 12.8% | 9.3% | 18.8% | 24.5% | 17.2% | 18.2% | 24.5% |
| Net income growth | β | 251.2% | 19.2% | β12.3% | 43.7% | 9.3% | 126.9% | β23.5% | 21.8% | 118.4% |
| EPS growth | β | 265.4% | 14.7% | β22.0% | 36.5% | 6.0% | 112.2% | β30.7% | 6.1% | 103.6% |
| Share count change | β | 14.8% | 11.9% | 12.6% | 5.3% | 3.8% | 6.8% | 10.3% | 15.0% | 7.2% |
| Financial health | ||||||||||
| Debt / equity | 0.5x | 0.4x | 0.4x | 0.3x | 0.3x | 0.4x | 0.3x | 0.3x | 0.2x | 0.2x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 8.7% | 6.6% | 6.1% | 6.2% | 5.3% | 4.3% | 3.7% | 4.2% | 3.9% | 3.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 5.0 | 4.0 | 6.0 | 3.0 | 5.0 | 4.0 | 4.0 | 4.0 |
| Accruals ratio | β2.7% | β1.2% | β0.9% | β2.0% | β1.0% | β1.8% | 1.8% | β0.8% | β1.1% | 2.6% |
Source: SEC EDGAR XBRL filings (CIK 0001476150). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.